Pathology Grand Rounds - Nuances and Pitfalls in Evaluating Treated IDH-Mutant Gliomas

At the conclusion of this activity, learners should be able to:

* Describe the natural history of IDH-mutant gliomas following standard therapies

* Explain the potential utility in resampling IDH-mutant gliomas after treatment

* Build a differential diagnosis when a supposed post-treatment IDH-mutant glioma specimen lacks a detectable IDH mutation